Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent
1992-08-20
1994-11-29
Wityshyn, Michael G.
Drug, bio-affecting and body treating compositions
Lymphokine
Interleukin
A61K 4505
Patent
active
053688546
ABSTRACT:
The invention provides in vivo methods and compositions for using IL-10 to treat inflammatory bowel disease in a mammal. The method comprises administering to the mammal an effective amount of IL-10, preferably intravascularly, alone or in combination with other therapeutic reagents.
REFERENCES:
Malefyt et al. J. Exp. Med. vol. 174 (Nov. 1991) pp. 1209-1220.
Peppercorn, Mark A. (1990) "Advances in Drug Therapy for Inflammatory Bowel Disease", Annals of Internal Medicine, 112:50-60.
Hanauer, Stephen B., et al. (1991) "Risk-Benefit Assessment of Drugs Used in the Treatment of Inflammatory Bowel Disease", Drug Safety 6 (3):192-219.
Linn, Frank V., et al. (1992) "Drug Therapy for Inflammatory Bowel Disease: Park I", The American Journal of Surgery, 164:85-89.
Linn, Frank V., et al. (1992) "Drug Therapy for Inflammatory Bowel Disease: Part II", The American Journal of Surgery, 164:178-185.
Grob, et al. "Inflammatory Mediators in Chronic Inflammatory Bowel Diseases", Klinische Wochen schrift, vol. 69, pp. 981-987, Apr. 24, 1991.
Apgar, et al., "Newer Aspects of Inflammatory Bowel Disease and its Cutaneous Manifestations: A Selective Review," Seminars in Dermatology, vol. 10, No. 3, pp. 138-147, Sep., 1991.
Goodnow, Christopher, C., "Transgenic Animals" in Roitt (ed.) Encyclopedia of Immunology, Academic Press, pp. 1502-1504, 1992.
James, Stephen P., "Cellular Immune Mechanisms in the Pathogenesis of Crohn's Disease," In vivo, vol. 2, pp. 1-8, 1988.
Jewell, D. P., Oxford Textbook of Medicine, Oxford University of Press, "Crohn's Disease," pp. 12.121-12.132.
Travis, John, "Scoring a Technical Knockout in Mice," Science, vol. 256, pp. 1392-1394, Jun. 5, 1992.
Kirsmer, "Inflammatory Bowel Disease", Disease Monitor, vol. 37, pp. 610-666, 1991.
Pullman, et al., "Enhanced Mucosal Cytokine Production in Inflammatory Bowel Disease," Gastroenterology, vol. 102, pp. 529-537, 1992.
Reinecker, et al., "Proinflammatory Cytokines in Intestinal Mucosa," Immunol Res. vol. 10, pp. 247-248, 1991.
Sawyerr, et al., "Review Article: the Pharmacological Implications of Leucocyte-Endothelial Cell Interactions in Crohn's Disease," Aliment. Pharmacol. Therap., vol. 5, pp. 1-14, 1991.
Schreiber, et al., "Die Rolle des Arachidonsaure-Stoffwechsels in der Pathophysiologie chronisch-entzundlicher Darmerkrankungen. Eicosanoids in Inflammatory Bowel Diseases," Immun. Infekt., vol. 18, pp. 115-120, Apr., 1990, (Abstract in English).
"Chronic Inflammation Diseases of the Bowel," Berkow (ed.), Merck Manual, Merck & Co., Rahway, New Jersey, pp. 797-806.
Ching Edwin P.
Dow Karen B.
O'Neal Lauren C.
Sayala C.
Schering Corporation
LandOfFree
Use of IL-10 to treat inflammatory bowel disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of IL-10 to treat inflammatory bowel disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of IL-10 to treat inflammatory bowel disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-72516